Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort

Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines

(2011) A. Kuznik et al.   JOURNAL OF IMMUNOLOGY

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

(2010) Hyejung Jung et al.   ARTHRITIS AND RHEUMATISM

Cytokine Networks in Systemic Lupus Erythematosus

(2010) Hooi-Ming Lee et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome

(2010) D. Smadja et al.   LUPUS

Interferon-alpha: A Therapeutic Target in Systemic Lupus Erythematosus

(2010) Mary K. Crow   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

(2009) Maria G. Tektonidou et al.   ARTHRITIS AND RHEUMATISM

Neutralization of interferon-α/β-inducible genes and downstream effect in a phase I trial of an anti-interferon-α monoclonal antibody in systemic lupus erythematosus

(2009) Yihong Yao et al.   ARTHRITIS AND RHEUMATISM

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study

(2009) Jason W. Bauer et al.   ARTHRITIS AND RHEUMATISM

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

(2009) J. H. Rand et al.   BLOOD

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort

(2008) R Kaiser et al.   ANNALS OF THE RHEUMATIC DISEASES

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody- 2-glycoprotein I complexes to phospholipid bilayers

(2008) J. H. Rand et al.   BLOOD